Marinus Pharmaceuticals Secures $20,000,000 Series B Funding Round

  • Feed Type
  • Date
    4/10/2009
  • Company Name
    Marinus Pharmaceuticals
  • Mailing Address
    21 Business Park Drive Branford, CT 06405
  • Company Description
    Marinus is a specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders. Marinus is located in Branford, Connecticut and its investors include Domain Associates, Canaan Partners, Sofinnova Ventures and Foundation Medical Partners.
  • Website
    http://www.marinuspharma.com/
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The funding will advance the Company’s ganaxolone development program for use as a novel adjunctive agent for the treatment of refractory partial seizures and to explore proof of concept studies in psychiatric indications.
  • M&A Terms
  • Venture Investor
    Canaan Partners
  • Venture Investor
    Domain Associates
  • Venture Investor
    Sofinnova Ventures
  • Venture Investor
    Foundation Medical Partners

By posting a comment, you agree to our terms and conditions.